FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Download Historical Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Insulin Lispro Injection
Status: Discontinuation
»Therapeutic Categories: Endocrinology/Metabolism

Expand all

Eli Lilly and Co. (New 09/01/2026)

Company Contact Information:
800-545-5979

Presentation	Posting Date	Related Information
Humalog, Injection, U-100 Tempo Pen (NDC 0002-8213-05)	10/24/2025	A business decision was made to discontinue manufacture of the drug.
Insulin Lispro Junior KwikPen, Injection, 100 [iU]/1 mL (NDC 0002-7752-05)	09/01/2026	A business decision was made to discontinue manufacture of the drug. Distribution projected to end June 2027. If patients or prescribers have any questions, the Lilly Answers Center (1-800-545-5979) is available Monday through Friday from 9am to 8pm for assistance.